Seller
Your price
£99.80
RRP: £129.99
Save £30.19 (23%)
Printed on Demand
Dispatched within 14-21 working days.
Trade or Institutional customer? Contact us about large order quotes.
Synopsis
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy. New & Used
| Seller | Information | Condition | Price | |
|---|---|---|---|---|
 | - | New | £99.80 + FREE UK P & P |
What Reviewers Are Saying
Be the first to review this item.
Submit your review now